Parachlamydia acanthamoebae, an emerging agent of pneumonia

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
A retrospective serological survey on human babesiosis in Belgium
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
Intracellular bacteria and adverse pregnancy outcomes
Mycoplasma pneumoniae—an emerging extra-pulmonary pathogen
Gut bacterial microbiota and obesity
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
C. Bertelli, G. Greub  Clinical Microbiology and Infection 
Genomics of medical importance
Evolution of extended-spectrum β-lactamases by mutation
C. Bertelli, G. Greub  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
O. Clerc, G. Greub  Clinical Microbiology and Infection 
The microarray technology: facts and controversies
G. Zhao, H. Zhai, Q. Yuan, S. Sun, T. Liu, L. Xie 
R. Cantón  Clinical Microbiology and Infection 
Link between intracellular pathogens and cardiovascular diseases
Non-antibiotic strategies for sepsis
Assessment of the cag pathogenicity island status of Helicobacter pylori infections with serology and PCR  M. Kivi, Y. Tindberg, C. Bengtsson, L. Engstrand,
B. Desnues, G. Imbert, D. Raoult, J.-L. Mege, E. Ghigo 
Vector control: a cornerstone in the malaria elimination campaign
Molecular mechanism of gentamicin resistance in Bartonella henselae
I.B. Salah, E. Ghigo, M. Drancourt  Clinical Microbiology and Infection 
A. Oliver, A. Mena  Clinical Microbiology and Infection 
Training for the infectious diseases speciality in Norway
V Nakano, R. M. F. Piazza, A. M. Cianciarullo, V Bueris, M. F
Isospora belli Clinical Microbiology and Infection
Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea  S.K. Niyogi,
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Elements of design: the knowledge on which we build
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
Levofloxacin in the treatment of ventilator-associated pneumonia
J.M. Kern, V. Maass, M. Maass  Clinical Microbiology and Infection 
Is quantitative PCR for the pneumolysin (ply) gene useful for detection of pneumococcal lower respiratory tract infection?  G. Abdeldaim, B. Herrmann,
Previously unknown species of Aspergillus
Infections and pregnancy: from a dream to a nightmare
T.M. File  Clinical Microbiology and Infection 
Diagnostic value of an ELISA using a recombinant 54-kDa species-specific protein from Chlamydia pneumoniae  J-M. Sueur, K. Beaumont, T. Cabioch, J. Orfila,
Abstracts cont. Clinical Microbiology and Infection
Y. Huang, B. Yang, W. Li  Clinical Microbiology and Infection 
Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds  J.H. Melendez, Y.M. Frankel, A.T.
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
D. Hvidsten, D.S. Halvorsen, B.P. Berdal, T.J. Gutteberg 
Salmonella L-forms: formation in human bile in vitro and isolation culture from patients' gallbladder samples by a non-high osmotic isolation technique 
Immunohistochemical detection of Coxiella burnetii in an aortic graft
Statin use and clinical outcomes among pneumonia patients
Isolation of Coxiella burnetii from the blood of a patient with positive Anaplasma phagocytophilum serological results  A.S. Santos, R. de Sousa, F. Alves,
The medical importance of Chlamydiae
Evaluation of the performance of the Helico Blot 2
O. Clerc, G. Greub  Clinical Microbiology and Infection 
Joanne L. Tipper, Eileen Ingham, Jonathan H. Cove, Neil J
Multiplexed whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm  F. Gouriet,
The atypical pneumonias: clinical diagnosis and importance
B. La Scola, D. Raoult  Clinical Microbiology and Infection 
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Zoonotic Chlamydophila psittaci infections from a clinical perspective
D. Baud, C. Kebbi, J.-P. Külling, G. Greub 
G.C. Schito  Clinical Microbiology and Infection 
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
A. Vankeerberghen, S. Jonckheere, H. De Raeve, R. Caluwe, H
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Parachlamydia acanthamoebae, an emerging agent of pneumonia G. Greub  Clinical Microbiology and Infection  Volume 15, Issue 1, Pages 18-28 (January 2009) DOI: 10.1111/j.1469-0691.2008.02633.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Schema of research programme aimed at discovering new bacterial species and further studying them to determine their role in lower respiratory tract infections, by developing different diagnostic tools to study patients with and without pneumonia, by determining the permissiveness of macrophages, pneumocytes and lung fibroblasts with respect to these obligate intracellular bacteria, and by studying the pathogenic properties of selected putative agents of pneumonia in a mouse model. Several new species have been discovered recently, including two members of the Criblamydiaceae family: Criblamydia sequanensis and Estrella lausannensis. The availability of these new bacterial species allows the production and purification of antigens useful for developing serological assays. Antigens are also used to immunize mice and rabbits to obtain polyclonal antibodies needed for cell biology, for immunohistochemistry, and as controls for serology. Diagnostic tools specifically developed include immunofluorescence, western blot, ELISA, PCR, immunohistochemistry and amoebal co-culture. Clinical Microbiology and Infection 2009 15, 18-28DOI: (10.1111/j.1469-0691.2008.02633.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 16S rRNA gene sequence divergence among different members of the Chlamydiales and the use of this ribosomal gene to classify a new strain at the family and genus levels, using cut-offs proposed by Everett et al. [7]. Clinical Microbiology and Infection 2009 15, 18-28DOI: (10.1111/j.1469-0691.2008.02633.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 (a) Confocal microscopy showing Parachlamydia acanthamoebae strain Hall's coccus within Acanthamoeba castellanii. The cell wall of P. acanthamoebae (in green) was stained with polyclonal mouse anti-Parachlamydia antibodies, whereas its DNA was stained with 4′,6-diamidino-2-phenylindole (DAPI). The amoeba was stained with concavalin A. 1000× magnification. (b) Electron microscopy showing Acanthamoeba polyphaga infected by P. acanthamoebae. Elementary bodies (arrowhead) and reticulate bodies (arrow) can be seen within the inclusions. N, amoebal nucleus. 3500× magnification. (c) Elementary body of P. acanthamoebae as viewed by electron microscopy. 70 000× magnification. (d) Crescent-shaped body of P. acanthamoebae as viewed by electron microscopy. 70 000× magnification. Clinical Microbiology and Infection 2009 15, 18-28DOI: (10.1111/j.1469-0691.2008.02633.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions